nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—CYP2D6—epilepsy syndrome	0.201	0.583	CbGaD
Acebutolol—ABCB1—epilepsy syndrome	0.144	0.417	CbGaD
Acebutolol—SLC22A1—Midazolam—epilepsy syndrome	0.0714	0.22	CbGbCtD
Acebutolol—ABCB1—Levetiracetam—epilepsy syndrome	0.0483	0.149	CbGbCtD
Acebutolol—ABCB1—Clobazam—epilepsy syndrome	0.0335	0.103	CbGbCtD
Acebutolol—ABCB1—Lamotrigine—epilepsy syndrome	0.0322	0.0992	CbGbCtD
Acebutolol—ABCB1—Carbamazepine—epilepsy syndrome	0.0278	0.0854	CbGbCtD
Acebutolol—ABCB1—Phenytoin—epilepsy syndrome	0.0249	0.0766	CbGbCtD
Acebutolol—ABCB1—Phenobarbital—epilepsy syndrome	0.0222	0.0683	CbGbCtD
Acebutolol—ABCB1—Midazolam—epilepsy syndrome	0.0219	0.0673	CbGbCtD
Acebutolol—CYP2D6—Propofol—epilepsy syndrome	0.0219	0.0673	CbGbCtD
Acebutolol—ABCB1—Diazepam—epilepsy syndrome	0.021	0.0647	CbGbCtD
Acebutolol—SLC22A1—ganglion—epilepsy syndrome	0.000555	0.153	CbGeAlD
Acebutolol—Metoprolol—CYP2C19—epilepsy syndrome	0.000285	0.12	CrCbGaD
Acebutolol—Betaxolol—CYP2D6—epilepsy syndrome	0.000274	0.115	CrCbGaD
Acebutolol—Bisoprolol—CYP2D6—epilepsy syndrome	0.000264	0.111	CrCbGaD
Acebutolol—Oxprenolol—CYP2D6—epilepsy syndrome	0.000249	0.105	CrCbGaD
Acebutolol—SLC22A1—forebrain—epilepsy syndrome	0.000233	0.0642	CbGeAlD
Acebutolol—Alprenolol—CYP2D6—epilepsy syndrome	0.000227	0.0956	CrCbGaD
Acebutolol—ADRB1—forebrain—epilepsy syndrome	0.000224	0.0619	CbGeAlD
Acebutolol—SLC22A1—telencephalon—epilepsy syndrome	0.000214	0.0591	CbGeAlD
Acebutolol—Metoprolol—CYP2D6—epilepsy syndrome	0.000211	0.0889	CrCbGaD
Acebutolol—ADRB1—telencephalon—epilepsy syndrome	0.000206	0.0569	CbGeAlD
Acebutolol—Pindolol—CYP2D6—epilepsy syndrome	0.000196	0.0823	CrCbGaD
Acebutolol—Atenolol—ABCB1—epilepsy syndrome	0.000194	0.0815	CrCbGaD
Acebutolol—CYP2D6—hindbrain—epilepsy syndrome	0.000189	0.0521	CbGeAlD
Acebutolol—Metoprolol—ABCB1—epilepsy syndrome	0.000151	0.0635	CrCbGaD
Acebutolol—Propranolol—CYP2C19—epilepsy syndrome	0.000144	0.0605	CrCbGaD
Acebutolol—SLC22A1—head—epilepsy syndrome	0.000133	0.0368	CbGeAlD
Acebutolol—ADRB1—head—epilepsy syndrome	0.000128	0.0354	CbGeAlD
Acebutolol—SLC22A1—nervous system—epilepsy syndrome	0.000126	0.0349	CbGeAlD
Acebutolol—ADRB1—nervous system—epilepsy syndrome	0.000122	0.0336	CbGeAlD
Acebutolol—SLC22A1—central nervous system—epilepsy syndrome	0.000122	0.0336	CbGeAlD
Acebutolol—ADRB1—central nervous system—epilepsy syndrome	0.000117	0.0323	CbGeAlD
Acebutolol—CYP2D6—brainstem—epilepsy syndrome	0.000108	0.0298	CbGeAlD
Acebutolol—Propranolol—CYP2D6—epilepsy syndrome	0.000107	0.0449	CrCbGaD
Acebutolol—CYP2D6—forebrain—epilepsy syndrome	0.000104	0.0288	CbGeAlD
Acebutolol—SLC22A1—brain—epilepsy syndrome	9.66e-05	0.0267	CbGeAlD
Acebutolol—CYP2D6—telencephalon—epilepsy syndrome	9.6e-05	0.0265	CbGeAlD
Acebutolol—ADRB1—brain—epilepsy syndrome	9.3e-05	0.0257	CbGeAlD
Acebutolol—Back pain—Gabapentin—epilepsy syndrome	8.56e-05	0.000356	CcSEcCtD
Acebutolol—Headache—Fosphenytoin—epilepsy syndrome	8.55e-05	0.000356	CcSEcCtD
Acebutolol—Nervous system disorder—Valproic Acid—epilepsy syndrome	8.54e-05	0.000356	CcSEcCtD
Acebutolol—Palpitations—Pregabalin—epilepsy syndrome	8.52e-05	0.000355	CcSEcCtD
Acebutolol—Asthenia—Phenytoin—epilepsy syndrome	8.52e-05	0.000355	CcSEcCtD
Acebutolol—Nausea—Midazolam—epilepsy syndrome	8.51e-05	0.000354	CcSEcCtD
Acebutolol—Hallucination—Topiramate—epilepsy syndrome	8.51e-05	0.000354	CcSEcCtD
Acebutolol—Hypoaesthesia—Topiramate—epilepsy syndrome	8.51e-05	0.000354	CcSEcCtD
Acebutolol—Diarrhoea—Zonisamide—epilepsy syndrome	8.49e-05	0.000354	CcSEcCtD
Acebutolol—Pharyngitis—Topiramate—epilepsy syndrome	8.48e-05	0.000353	CcSEcCtD
Acebutolol—Loss of consciousness—Pregabalin—epilepsy syndrome	8.48e-05	0.000353	CcSEcCtD
Acebutolol—Asthenia—Oxcarbazepine—epilepsy syndrome	8.48e-05	0.000353	CcSEcCtD
Acebutolol—Pruritus—Clonazepam—epilepsy syndrome	8.46e-05	0.000352	CcSEcCtD
Acebutolol—Vomiting—Vigabatrin—epilepsy syndrome	8.46e-05	0.000352	CcSEcCtD
Acebutolol—Skin disorder—Valproic Acid—epilepsy syndrome	8.46e-05	0.000352	CcSEcCtD
Acebutolol—Hyperhidrosis—Valproic Acid—epilepsy syndrome	8.42e-05	0.000351	CcSEcCtD
Acebutolol—Cough—Pregabalin—epilepsy syndrome	8.42e-05	0.000351	CcSEcCtD
Acebutolol—Pruritus—Phenytoin—epilepsy syndrome	8.4e-05	0.00035	CcSEcCtD
Acebutolol—Connective tissue disorder—Topiramate—epilepsy syndrome	8.4e-05	0.00035	CcSEcCtD
Acebutolol—Nausea—Levetiracetam—epilepsy syndrome	8.4e-05	0.00035	CcSEcCtD
Acebutolol—Rash—Vigabatrin—epilepsy syndrome	8.39e-05	0.000349	CcSEcCtD
Acebutolol—Dizziness—Felbamate—epilepsy syndrome	8.38e-05	0.000349	CcSEcCtD
Acebutolol—Dermatitis—Vigabatrin—epilepsy syndrome	8.38e-05	0.000349	CcSEcCtD
Acebutolol—Pruritus—Oxcarbazepine—epilepsy syndrome	8.36e-05	0.000348	CcSEcCtD
Acebutolol—Vision blurred—Gabapentin—epilepsy syndrome	8.34e-05	0.000347	CcSEcCtD
Acebutolol—Headache—Vigabatrin—epilepsy syndrome	8.33e-05	0.000347	CcSEcCtD
Acebutolol—Vomiting—Diazepam—epilepsy syndrome	8.33e-05	0.000347	CcSEcCtD
Acebutolol—Anorexia—Valproic Acid—epilepsy syndrome	8.3e-05	0.000346	CcSEcCtD
Acebutolol—Rash—Diazepam—epilepsy syndrome	8.26e-05	0.000344	CcSEcCtD
Acebutolol—Dermatitis—Diazepam—epilepsy syndrome	8.25e-05	0.000344	CcSEcCtD
Acebutolol—Visual impairment—Topiramate—epilepsy syndrome	8.24e-05	0.000343	CcSEcCtD
Acebutolol—Arthralgia—Pregabalin—epilepsy syndrome	8.21e-05	0.000342	CcSEcCtD
Acebutolol—Chest pain—Pregabalin—epilepsy syndrome	8.21e-05	0.000342	CcSEcCtD
Acebutolol—Myalgia—Pregabalin—epilepsy syndrome	8.21e-05	0.000342	CcSEcCtD
Acebutolol—Ill-defined disorder—Gabapentin—epilepsy syndrome	8.21e-05	0.000342	CcSEcCtD
Acebutolol—Dizziness—Zonisamide—epilepsy syndrome	8.21e-05	0.000342	CcSEcCtD
Acebutolol—Headache—Diazepam—epilepsy syndrome	8.21e-05	0.000342	CcSEcCtD
Acebutolol—Anxiety—Pregabalin—epilepsy syndrome	8.18e-05	0.000341	CcSEcCtD
Acebutolol—Diarrhoea—Clonazepam—epilepsy syndrome	8.18e-05	0.000341	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	8.16e-05	0.00034	CcSEcCtD
Acebutolol—Hypotension—Valproic Acid—epilepsy syndrome	8.14e-05	0.000339	CcSEcCtD
Acebutolol—Asthenia—Carbamazepine—epilepsy syndrome	8.14e-05	0.000339	CcSEcCtD
Acebutolol—Diarrhoea—Phenytoin—epilepsy syndrome	8.13e-05	0.000338	CcSEcCtD
Acebutolol—Discomfort—Pregabalin—epilepsy syndrome	8.11e-05	0.000338	CcSEcCtD
Acebutolol—Nausea—Fosphenytoin—epilepsy syndrome	8.11e-05	0.000338	CcSEcCtD
Acebutolol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	8.08e-05	0.000337	CcSEcCtD
Acebutolol—Vomiting—Felbamate—epilepsy syndrome	8.06e-05	0.000336	CcSEcCtD
Acebutolol—Pruritus—Carbamazepine—epilepsy syndrome	8.02e-05	0.000334	CcSEcCtD
Acebutolol—Rash—Felbamate—epilepsy syndrome	7.99e-05	0.000333	CcSEcCtD
Acebutolol—Dermatitis—Felbamate—epilepsy syndrome	7.99e-05	0.000333	CcSEcCtD
Acebutolol—Malaise—Gabapentin—epilepsy syndrome	7.98e-05	0.000332	CcSEcCtD
Acebutolol—Tinnitus—Topiramate—epilepsy syndrome	7.97e-05	0.000332	CcSEcCtD
Acebutolol—Vertigo—Gabapentin—epilepsy syndrome	7.95e-05	0.000331	CcSEcCtD
Acebutolol—Headache—Felbamate—epilepsy syndrome	7.94e-05	0.000331	CcSEcCtD
Acebutolol—Confusional state—Pregabalin—epilepsy syndrome	7.94e-05	0.000331	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	7.93e-05	0.00033	CcSEcCtD
Acebutolol—Flushing—Topiramate—epilepsy syndrome	7.93e-05	0.00033	CcSEcCtD
Acebutolol—Syncope—Gabapentin—epilepsy syndrome	7.93e-05	0.00033	CcSEcCtD
Acebutolol—Dizziness—Clonazepam—epilepsy syndrome	7.91e-05	0.000329	CcSEcCtD
Acebutolol—Nausea—Vigabatrin—epilepsy syndrome	7.9e-05	0.000329	CcSEcCtD
Acebutolol—Vomiting—Zonisamide—epilepsy syndrome	7.89e-05	0.000329	CcSEcCtD
Acebutolol—Insomnia—Valproic Acid—epilepsy syndrome	7.88e-05	0.000328	CcSEcCtD
Acebutolol—Oedema—Pregabalin—epilepsy syndrome	7.87e-05	0.000328	CcSEcCtD
Acebutolol—Asthenia—Lamotrigine—epilepsy syndrome	7.86e-05	0.000327	CcSEcCtD
Acebutolol—Dizziness—Phenytoin—epilepsy syndrome	7.86e-05	0.000327	CcSEcCtD
Acebutolol—Rash—Zonisamide—epilepsy syndrome	7.82e-05	0.000326	CcSEcCtD
Acebutolol—Paraesthesia—Valproic Acid—epilepsy syndrome	7.82e-05	0.000326	CcSEcCtD
Acebutolol—Palpitations—Gabapentin—epilepsy syndrome	7.82e-05	0.000326	CcSEcCtD
Acebutolol—Dermatitis—Zonisamide—epilepsy syndrome	7.82e-05	0.000326	CcSEcCtD
Acebutolol—Dizziness—Oxcarbazepine—epilepsy syndrome	7.81e-05	0.000325	CcSEcCtD
Acebutolol—Nausea—Diazepam—epilepsy syndrome	7.78e-05	0.000324	CcSEcCtD
Acebutolol—Loss of consciousness—Gabapentin—epilepsy syndrome	7.77e-05	0.000324	CcSEcCtD
Acebutolol—Headache—Zonisamide—epilepsy syndrome	7.77e-05	0.000324	CcSEcCtD
Acebutolol—Dyspnoea—Valproic Acid—epilepsy syndrome	7.76e-05	0.000323	CcSEcCtD
Acebutolol—Diarrhoea—Carbamazepine—epilepsy syndrome	7.76e-05	0.000323	CcSEcCtD
Acebutolol—Angiopathy—Topiramate—epilepsy syndrome	7.76e-05	0.000323	CcSEcCtD
Acebutolol—Pruritus—Lamotrigine—epilepsy syndrome	7.75e-05	0.000323	CcSEcCtD
Acebutolol—Shock—Pregabalin—epilepsy syndrome	7.75e-05	0.000323	CcSEcCtD
Acebutolol—Somnolence—Valproic Acid—epilepsy syndrome	7.74e-05	0.000322	CcSEcCtD
Acebutolol—Nervous system disorder—Pregabalin—epilepsy syndrome	7.72e-05	0.000322	CcSEcCtD
Acebutolol—Cough—Gabapentin—epilepsy syndrome	7.72e-05	0.000321	CcSEcCtD
Acebutolol—Mediastinal disorder—Topiramate—epilepsy syndrome	7.7e-05	0.000321	CcSEcCtD
Acebutolol—Chills—Topiramate—epilepsy syndrome	7.67e-05	0.000319	CcSEcCtD
Acebutolol—Dyspepsia—Valproic Acid—epilepsy syndrome	7.67e-05	0.000319	CcSEcCtD
Acebutolol—Skin disorder—Pregabalin—epilepsy syndrome	7.65e-05	0.000318	CcSEcCtD
Acebutolol—Propranolol—ABCB1—epilepsy syndrome	7.62e-05	0.032	CrCbGaD
Acebutolol—Hyperhidrosis—Pregabalin—epilepsy syndrome	7.61e-05	0.000317	CcSEcCtD
Acebutolol—Vomiting—Clonazepam—epilepsy syndrome	7.6e-05	0.000317	CcSEcCtD
Acebutolol—Decreased appetite—Valproic Acid—epilepsy syndrome	7.57e-05	0.000315	CcSEcCtD
Acebutolol—Alopecia—Topiramate—epilepsy syndrome	7.55e-05	0.000315	CcSEcCtD
Acebutolol—Vomiting—Phenytoin—epilepsy syndrome	7.55e-05	0.000315	CcSEcCtD
Acebutolol—Rash—Clonazepam—epilepsy syndrome	7.54e-05	0.000314	CcSEcCtD
Acebutolol—Dermatitis—Clonazepam—epilepsy syndrome	7.53e-05	0.000314	CcSEcCtD
Acebutolol—Myalgia—Gabapentin—epilepsy syndrome	7.53e-05	0.000314	CcSEcCtD
Acebutolol—Arthralgia—Gabapentin—epilepsy syndrome	7.53e-05	0.000314	CcSEcCtD
Acebutolol—Chest pain—Gabapentin—epilepsy syndrome	7.53e-05	0.000314	CcSEcCtD
Acebutolol—Nausea—Felbamate—epilepsy syndrome	7.53e-05	0.000314	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	7.52e-05	0.000313	CcSEcCtD
Acebutolol—Vomiting—Oxcarbazepine—epilepsy syndrome	7.51e-05	0.000313	CcSEcCtD
Acebutolol—ABCB1—forebrain—epilepsy syndrome	7.51e-05	0.0207	CbGeAlD
Acebutolol—Fatigue—Valproic Acid—epilepsy syndrome	7.51e-05	0.000313	CcSEcCtD
Acebutolol—Anxiety—Gabapentin—epilepsy syndrome	7.5e-05	0.000313	CcSEcCtD
Acebutolol—Anorexia—Pregabalin—epilepsy syndrome	7.5e-05	0.000313	CcSEcCtD
Acebutolol—Dizziness—Carbamazepine—epilepsy syndrome	7.5e-05	0.000312	CcSEcCtD
Acebutolol—Diarrhoea—Lamotrigine—epilepsy syndrome	7.5e-05	0.000312	CcSEcCtD
Acebutolol—Headache—Clonazepam—epilepsy syndrome	7.49e-05	0.000312	CcSEcCtD
Acebutolol—Rash—Phenytoin—epilepsy syndrome	7.49e-05	0.000312	CcSEcCtD
Acebutolol—Dermatitis—Phenytoin—epilepsy syndrome	7.48e-05	0.000312	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	7.48e-05	0.000311	CcSEcCtD
Acebutolol—Rash—Oxcarbazepine—epilepsy syndrome	7.45e-05	0.00031	CcSEcCtD
Acebutolol—Pain—Valproic Acid—epilepsy syndrome	7.45e-05	0.00031	CcSEcCtD
Acebutolol—Constipation—Valproic Acid—epilepsy syndrome	7.45e-05	0.00031	CcSEcCtD
Acebutolol—Dermatitis—Oxcarbazepine—epilepsy syndrome	7.44e-05	0.00031	CcSEcCtD
Acebutolol—Headache—Phenytoin—epilepsy syndrome	7.44e-05	0.00031	CcSEcCtD
Acebutolol—Discomfort—Gabapentin—epilepsy syndrome	7.44e-05	0.00031	CcSEcCtD
Acebutolol—Headache—Oxcarbazepine—epilepsy syndrome	7.4e-05	0.000308	CcSEcCtD
Acebutolol—Nausea—Zonisamide—epilepsy syndrome	7.37e-05	0.000307	CcSEcCtD
Acebutolol—Hypotension—Pregabalin—epilepsy syndrome	7.36e-05	0.000306	CcSEcCtD
Acebutolol—Flatulence—Topiramate—epilepsy syndrome	7.33e-05	0.000305	CcSEcCtD
Acebutolol—Confusional state—Gabapentin—epilepsy syndrome	7.28e-05	0.000303	CcSEcCtD
Acebutolol—Dizziness—Lamotrigine—epilepsy syndrome	7.25e-05	0.000302	CcSEcCtD
Acebutolol—Oedema—Gabapentin—epilepsy syndrome	7.22e-05	0.000301	CcSEcCtD
Acebutolol—Vomiting—Carbamazepine—epilepsy syndrome	7.21e-05	0.0003	CcSEcCtD
Acebutolol—Back pain—Topiramate—epilepsy syndrome	7.2e-05	0.0003	CcSEcCtD
Acebutolol—Feeling abnormal—Valproic Acid—epilepsy syndrome	7.18e-05	0.000299	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	7.17e-05	0.000299	CcSEcCtD
Acebutolol—Rash—Carbamazepine—epilepsy syndrome	7.15e-05	0.000298	CcSEcCtD
Acebutolol—Dermatitis—Carbamazepine—epilepsy syndrome	7.14e-05	0.000297	CcSEcCtD
Acebutolol—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	7.12e-05	0.000297	CcSEcCtD
Acebutolol—Insomnia—Pregabalin—epilepsy syndrome	7.12e-05	0.000297	CcSEcCtD
Acebutolol—Nausea—Clonazepam—epilepsy syndrome	7.1e-05	0.000296	CcSEcCtD
Acebutolol—Headache—Carbamazepine—epilepsy syndrome	7.1e-05	0.000296	CcSEcCtD
Acebutolol—Shock—Gabapentin—epilepsy syndrome	7.1e-05	0.000296	CcSEcCtD
Acebutolol—Nervous system disorder—Gabapentin—epilepsy syndrome	7.08e-05	0.000295	CcSEcCtD
Acebutolol—Paraesthesia—Pregabalin—epilepsy syndrome	7.07e-05	0.000294	CcSEcCtD
Acebutolol—Nausea—Phenytoin—epilepsy syndrome	7.06e-05	0.000294	CcSEcCtD
Acebutolol—Dyspnoea—Pregabalin—epilepsy syndrome	7.02e-05	0.000292	CcSEcCtD
Acebutolol—Nausea—Oxcarbazepine—epilepsy syndrome	7.02e-05	0.000292	CcSEcCtD
Acebutolol—Vision blurred—Topiramate—epilepsy syndrome	7.01e-05	0.000292	CcSEcCtD
Acebutolol—Skin disorder—Gabapentin—epilepsy syndrome	7.01e-05	0.000292	CcSEcCtD
Acebutolol—Somnolence—Pregabalin—epilepsy syndrome	7e-05	0.000291	CcSEcCtD
Acebutolol—Hyperhidrosis—Gabapentin—epilepsy syndrome	6.98e-05	0.000291	CcSEcCtD
Acebutolol—Vomiting—Lamotrigine—epilepsy syndrome	6.97e-05	0.00029	CcSEcCtD
Acebutolol—Urticaria—Valproic Acid—epilepsy syndrome	6.92e-05	0.000288	CcSEcCtD
Acebutolol—Rash—Lamotrigine—epilepsy syndrome	6.91e-05	0.000288	CcSEcCtD
Acebutolol—ABCB1—telencephalon—epilepsy syndrome	6.91e-05	0.0191	CbGeAlD
Acebutolol—Ill-defined disorder—Topiramate—epilepsy syndrome	6.9e-05	0.000288	CcSEcCtD
Acebutolol—Dermatitis—Lamotrigine—epilepsy syndrome	6.9e-05	0.000288	CcSEcCtD
Acebutolol—Abdominal pain—Valproic Acid—epilepsy syndrome	6.88e-05	0.000287	CcSEcCtD
Acebutolol—Body temperature increased—Valproic Acid—epilepsy syndrome	6.88e-05	0.000287	CcSEcCtD
Acebutolol—Anorexia—Gabapentin—epilepsy syndrome	6.88e-05	0.000287	CcSEcCtD
Acebutolol—Headache—Lamotrigine—epilepsy syndrome	6.87e-05	0.000286	CcSEcCtD
Acebutolol—Decreased appetite—Pregabalin—epilepsy syndrome	6.84e-05	0.000285	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.8e-05	0.000283	CcSEcCtD
Acebutolol—Fatigue—Pregabalin—epilepsy syndrome	6.79e-05	0.000283	CcSEcCtD
Acebutolol—Hypotension—Gabapentin—epilepsy syndrome	6.75e-05	0.000281	CcSEcCtD
Acebutolol—Nausea—Carbamazepine—epilepsy syndrome	6.74e-05	0.000281	CcSEcCtD
Acebutolol—Constipation—Pregabalin—epilepsy syndrome	6.73e-05	0.00028	CcSEcCtD
Acebutolol—Pain—Pregabalin—epilepsy syndrome	6.73e-05	0.00028	CcSEcCtD
Acebutolol—Malaise—Topiramate—epilepsy syndrome	6.71e-05	0.000279	CcSEcCtD
Acebutolol—Vertigo—Topiramate—epilepsy syndrome	6.69e-05	0.000278	CcSEcCtD
Acebutolol—Syncope—Topiramate—epilepsy syndrome	6.67e-05	0.000278	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	6.58e-05	0.000274	CcSEcCtD
Acebutolol—Palpitations—Topiramate—epilepsy syndrome	6.58e-05	0.000274	CcSEcCtD
Acebutolol—Loss of consciousness—Topiramate—epilepsy syndrome	6.54e-05	0.000272	CcSEcCtD
Acebutolol—Insomnia—Gabapentin—epilepsy syndrome	6.53e-05	0.000272	CcSEcCtD
Acebutolol—Nausea—Lamotrigine—epilepsy syndrome	6.51e-05	0.000271	CcSEcCtD
Acebutolol—Cough—Topiramate—epilepsy syndrome	6.49e-05	0.00027	CcSEcCtD
Acebutolol—Feeling abnormal—Pregabalin—epilepsy syndrome	6.49e-05	0.00027	CcSEcCtD
Acebutolol—Paraesthesia—Gabapentin—epilepsy syndrome	6.48e-05	0.00027	CcSEcCtD
Acebutolol—Gastrointestinal pain—Pregabalin—epilepsy syndrome	6.44e-05	0.000268	CcSEcCtD
Acebutolol—Dyspnoea—Gabapentin—epilepsy syndrome	6.44e-05	0.000268	CcSEcCtD
Acebutolol—Somnolence—Gabapentin—epilepsy syndrome	6.42e-05	0.000267	CcSEcCtD
Acebutolol—Dyspepsia—Gabapentin—epilepsy syndrome	6.35e-05	0.000265	CcSEcCtD
Acebutolol—Myalgia—Topiramate—epilepsy syndrome	6.34e-05	0.000264	CcSEcCtD
Acebutolol—Arthralgia—Topiramate—epilepsy syndrome	6.34e-05	0.000264	CcSEcCtD
Acebutolol—Chest pain—Topiramate—epilepsy syndrome	6.34e-05	0.000264	CcSEcCtD
Acebutolol—Anxiety—Topiramate—epilepsy syndrome	6.31e-05	0.000263	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	6.29e-05	0.000262	CcSEcCtD
Acebutolol—Decreased appetite—Gabapentin—epilepsy syndrome	6.28e-05	0.000261	CcSEcCtD
Acebutolol—Discomfort—Topiramate—epilepsy syndrome	6.26e-05	0.000261	CcSEcCtD
Acebutolol—Urticaria—Pregabalin—epilepsy syndrome	6.25e-05	0.00026	CcSEcCtD
Acebutolol—Asthenia—Valproic Acid—epilepsy syndrome	6.25e-05	0.00026	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.23e-05	0.00026	CcSEcCtD
Acebutolol—Fatigue—Gabapentin—epilepsy syndrome	6.22e-05	0.000259	CcSEcCtD
Acebutolol—Body temperature increased—Pregabalin—epilepsy syndrome	6.22e-05	0.000259	CcSEcCtD
Acebutolol—Abdominal pain—Pregabalin—epilepsy syndrome	6.22e-05	0.000259	CcSEcCtD
Acebutolol—Pain—Gabapentin—epilepsy syndrome	6.17e-05	0.000257	CcSEcCtD
Acebutolol—Constipation—Gabapentin—epilepsy syndrome	6.17e-05	0.000257	CcSEcCtD
Acebutolol—Pruritus—Valproic Acid—epilepsy syndrome	6.16e-05	0.000257	CcSEcCtD
Acebutolol—Confusional state—Topiramate—epilepsy syndrome	6.12e-05	0.000255	CcSEcCtD
Acebutolol—Oedema—Topiramate—epilepsy syndrome	6.07e-05	0.000253	CcSEcCtD
Acebutolol—CYP2D6—head—epilepsy syndrome	5.98e-05	0.0165	CbGeAlD
Acebutolol—Shock—Topiramate—epilepsy syndrome	5.98e-05	0.000249	CcSEcCtD
Acebutolol—Diarrhoea—Valproic Acid—epilepsy syndrome	5.96e-05	0.000248	CcSEcCtD
Acebutolol—Nervous system disorder—Topiramate—epilepsy syndrome	5.96e-05	0.000248	CcSEcCtD
Acebutolol—Feeling abnormal—Gabapentin—epilepsy syndrome	5.95e-05	0.000248	CcSEcCtD
Acebutolol—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.9e-05	0.000246	CcSEcCtD
Acebutolol—Skin disorder—Topiramate—epilepsy syndrome	5.9e-05	0.000246	CcSEcCtD
Acebutolol—Hyperhidrosis—Topiramate—epilepsy syndrome	5.87e-05	0.000245	CcSEcCtD
Acebutolol—Anorexia—Topiramate—epilepsy syndrome	5.79e-05	0.000241	CcSEcCtD
Acebutolol—Dizziness—Valproic Acid—epilepsy syndrome	5.76e-05	0.00024	CcSEcCtD
Acebutolol—Urticaria—Gabapentin—epilepsy syndrome	5.73e-05	0.000239	CcSEcCtD
Acebutolol—Body temperature increased—Gabapentin—epilepsy syndrome	5.71e-05	0.000238	CcSEcCtD
Acebutolol—Abdominal pain—Gabapentin—epilepsy syndrome	5.71e-05	0.000238	CcSEcCtD
Acebutolol—Hypotension—Topiramate—epilepsy syndrome	5.68e-05	0.000236	CcSEcCtD
Acebutolol—CYP2D6—nervous system—epilepsy syndrome	5.67e-05	0.0156	CbGeAlD
Acebutolol—Asthenia—Pregabalin—epilepsy syndrome	5.65e-05	0.000235	CcSEcCtD
Acebutolol—Pruritus—Pregabalin—epilepsy syndrome	5.57e-05	0.000232	CcSEcCtD
Acebutolol—Vomiting—Valproic Acid—epilepsy syndrome	5.54e-05	0.000231	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	5.53e-05	0.00023	CcSEcCtD
Acebutolol—Insomnia—Topiramate—epilepsy syndrome	5.49e-05	0.000229	CcSEcCtD
Acebutolol—Rash—Valproic Acid—epilepsy syndrome	5.49e-05	0.000229	CcSEcCtD
Acebutolol—Dermatitis—Valproic Acid—epilepsy syndrome	5.49e-05	0.000228	CcSEcCtD
Acebutolol—CYP2D6—central nervous system—epilepsy syndrome	5.46e-05	0.0151	CbGeAlD
Acebutolol—Headache—Valproic Acid—epilepsy syndrome	5.46e-05	0.000227	CcSEcCtD
Acebutolol—Paraesthesia—Topiramate—epilepsy syndrome	5.45e-05	0.000227	CcSEcCtD
Acebutolol—ABCB1—medulla oblongata—epilepsy syndrome	5.43e-05	0.015	CbGeAlD
Acebutolol—Dyspnoea—Topiramate—epilepsy syndrome	5.41e-05	0.000226	CcSEcCtD
Acebutolol—Somnolence—Topiramate—epilepsy syndrome	5.4e-05	0.000225	CcSEcCtD
Acebutolol—Diarrhoea—Pregabalin—epilepsy syndrome	5.39e-05	0.000224	CcSEcCtD
Acebutolol—Dyspepsia—Topiramate—epilepsy syndrome	5.35e-05	0.000223	CcSEcCtD
Acebutolol—CYP2D6—cerebellum—epilepsy syndrome	5.33e-05	0.0147	CbGeAlD
Acebutolol—Decreased appetite—Topiramate—epilepsy syndrome	5.28e-05	0.00022	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.24e-05	0.000218	CcSEcCtD
Acebutolol—Fatigue—Topiramate—epilepsy syndrome	5.24e-05	0.000218	CcSEcCtD
Acebutolol—Dizziness—Pregabalin—epilepsy syndrome	5.21e-05	0.000217	CcSEcCtD
Acebutolol—Pain—Topiramate—epilepsy syndrome	5.19e-05	0.000216	CcSEcCtD
Acebutolol—Constipation—Topiramate—epilepsy syndrome	5.19e-05	0.000216	CcSEcCtD
Acebutolol—Asthenia—Gabapentin—epilepsy syndrome	5.18e-05	0.000216	CcSEcCtD
Acebutolol—Nausea—Valproic Acid—epilepsy syndrome	5.17e-05	0.000215	CcSEcCtD
Acebutolol—Pruritus—Gabapentin—epilepsy syndrome	5.11e-05	0.000213	CcSEcCtD
Acebutolol—Vomiting—Pregabalin—epilepsy syndrome	5.01e-05	0.000208	CcSEcCtD
Acebutolol—Feeling abnormal—Topiramate—epilepsy syndrome	5e-05	0.000208	CcSEcCtD
Acebutolol—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.97e-05	0.000207	CcSEcCtD
Acebutolol—Rash—Pregabalin—epilepsy syndrome	4.96e-05	0.000207	CcSEcCtD
Acebutolol—ABCB1—midbrain—epilepsy syndrome	4.96e-05	0.0137	CbGeAlD
Acebutolol—Dermatitis—Pregabalin—epilepsy syndrome	4.96e-05	0.000207	CcSEcCtD
Acebutolol—Diarrhoea—Gabapentin—epilepsy syndrome	4.94e-05	0.000206	CcSEcCtD
Acebutolol—Headache—Pregabalin—epilepsy syndrome	4.93e-05	0.000205	CcSEcCtD
Acebutolol—ABCB1—spinal cord—epilepsy syndrome	4.84e-05	0.0133	CbGeAlD
Acebutolol—Urticaria—Topiramate—epilepsy syndrome	4.82e-05	0.000201	CcSEcCtD
Acebutolol—Body temperature increased—Topiramate—epilepsy syndrome	4.8e-05	0.0002	CcSEcCtD
Acebutolol—Abdominal pain—Topiramate—epilepsy syndrome	4.8e-05	0.0002	CcSEcCtD
Acebutolol—Dizziness—Gabapentin—epilepsy syndrome	4.77e-05	0.000199	CcSEcCtD
Acebutolol—Nausea—Pregabalin—epilepsy syndrome	4.68e-05	0.000195	CcSEcCtD
Acebutolol—Vomiting—Gabapentin—epilepsy syndrome	4.59e-05	0.000191	CcSEcCtD
Acebutolol—Rash—Gabapentin—epilepsy syndrome	4.55e-05	0.00019	CcSEcCtD
Acebutolol—Dermatitis—Gabapentin—epilepsy syndrome	4.55e-05	0.000189	CcSEcCtD
Acebutolol—Headache—Gabapentin—epilepsy syndrome	4.52e-05	0.000188	CcSEcCtD
Acebutolol—Asthenia—Topiramate—epilepsy syndrome	4.36e-05	0.000181	CcSEcCtD
Acebutolol—CYP2D6—brain—epilepsy syndrome	4.33e-05	0.012	CbGeAlD
Acebutolol—ABCB1—head—epilepsy syndrome	4.3e-05	0.0119	CbGeAlD
Acebutolol—Pruritus—Topiramate—epilepsy syndrome	4.3e-05	0.000179	CcSEcCtD
Acebutolol—Nausea—Gabapentin—epilepsy syndrome	4.29e-05	0.000179	CcSEcCtD
Acebutolol—Diarrhoea—Topiramate—epilepsy syndrome	4.16e-05	0.000173	CcSEcCtD
Acebutolol—ABCB1—nervous system—epilepsy syndrome	4.08e-05	0.0112	CbGeAlD
Acebutolol—Dizziness—Topiramate—epilepsy syndrome	4.02e-05	0.000167	CcSEcCtD
Acebutolol—ABCB1—central nervous system—epilepsy syndrome	3.93e-05	0.0108	CbGeAlD
Acebutolol—Vomiting—Topiramate—epilepsy syndrome	3.86e-05	0.000161	CcSEcCtD
Acebutolol—ABCB1—cerebellum—epilepsy syndrome	3.84e-05	0.0106	CbGeAlD
Acebutolol—Rash—Topiramate—epilepsy syndrome	3.83e-05	0.000159	CcSEcCtD
Acebutolol—Dermatitis—Topiramate—epilepsy syndrome	3.83e-05	0.000159	CcSEcCtD
Acebutolol—Headache—Topiramate—epilepsy syndrome	3.8e-05	0.000158	CcSEcCtD
Acebutolol—Nausea—Topiramate—epilepsy syndrome	3.61e-05	0.00015	CcSEcCtD
Acebutolol—ABCB1—brain—epilepsy syndrome	3.12e-05	0.0086	CbGeAlD
Acebutolol—ADRB1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.65e-05	0.000196	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CHRM2—epilepsy syndrome	1.65e-05	0.000196	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CX3CR1—epilepsy syndrome	1.64e-05	0.000195	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	1.63e-05	0.000194	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CHRM2—epilepsy syndrome	1.61e-05	0.000192	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CX3CL1—epilepsy syndrome	1.61e-05	0.000192	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—BDKRB1—epilepsy syndrome	1.61e-05	0.000192	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CDC42—epilepsy syndrome	1.61e-05	0.000191	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GABBR1—epilepsy syndrome	1.6e-05	0.000191	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	1.59e-05	0.000189	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GBE1—epilepsy syndrome	1.59e-05	0.000189	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ASAH1—epilepsy syndrome	1.59e-05	0.000189	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CDC42—epilepsy syndrome	1.57e-05	0.000187	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.57e-05	0.000187	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GABBR1—epilepsy syndrome	1.57e-05	0.000186	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—AVP—epilepsy syndrome	1.56e-05	0.000185	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—STXBP1—epilepsy syndrome	1.55e-05	0.000184	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HRH3—epilepsy syndrome	1.54e-05	0.000183	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—AVP—epilepsy syndrome	1.52e-05	0.000181	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ABCG2—epilepsy syndrome	1.51e-05	0.00018	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.51e-05	0.00018	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—OPRM1—epilepsy syndrome	1.51e-05	0.00018	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NT5E—epilepsy syndrome	1.51e-05	0.000179	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ALAD—epilepsy syndrome	1.51e-05	0.000179	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HRH3—epilepsy syndrome	1.5e-05	0.000179	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.5e-05	0.000178	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	1.5e-05	0.000178	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—OPRM1—epilepsy syndrome	1.48e-05	0.000176	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CYP2C19—epilepsy syndrome	1.48e-05	0.000176	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.47e-05	0.000175	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CYP11A1—epilepsy syndrome	1.47e-05	0.000174	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.46e-05	0.000173	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	1.46e-05	0.000173	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	1.44e-05	0.000171	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	1.44e-05	0.000171	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCR3—epilepsy syndrome	1.43e-05	0.00017	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.43e-05	0.00017	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.43e-05	0.00017	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NT5E—epilepsy syndrome	1.42e-05	0.000169	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ALAD—epilepsy syndrome	1.42e-05	0.000169	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	1.41e-05	0.000167	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCR3—epilepsy syndrome	1.4e-05	0.000166	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.4e-05	0.000166	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NPY—epilepsy syndrome	1.39e-05	0.000165	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.39e-05	0.000165	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ADSL—epilepsy syndrome	1.38e-05	0.000164	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NPY—epilepsy syndrome	1.36e-05	0.000162	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.36e-05	0.000162	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—AGT—epilepsy syndrome	1.35e-05	0.000161	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	1.35e-05	0.000161	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	1.35e-05	0.000161	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GLUL—epilepsy syndrome	1.35e-05	0.000161	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCL2—epilepsy syndrome	1.34e-05	0.00016	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—OXT—epilepsy syndrome	1.34e-05	0.00016	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CRH—epilepsy syndrome	1.34e-05	0.00016	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCL3—epilepsy syndrome	1.34e-05	0.00016	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HSPB1—epilepsy syndrome	1.34e-05	0.00016	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	1.33e-05	0.000158	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	1.33e-05	0.000158	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—AGT—epilepsy syndrome	1.32e-05	0.000158	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CCR5—epilepsy syndrome	1.32e-05	0.000158	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CYP2D6—epilepsy syndrome	1.32e-05	0.000157	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.32e-05	0.000157	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HSPB1—epilepsy syndrome	1.31e-05	0.000156	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCL3—epilepsy syndrome	1.31e-05	0.000156	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—OXT—epilepsy syndrome	1.31e-05	0.000156	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CRH—epilepsy syndrome	1.31e-05	0.000156	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCL2—epilepsy syndrome	1.31e-05	0.000156	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ADSL—epilepsy syndrome	1.3e-05	0.000154	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.3e-05	0.000154	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CCR5—epilepsy syndrome	1.3e-05	0.000154	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.28e-05	0.000153	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GLUL—epilepsy syndrome	1.27e-05	0.000151	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.27e-05	0.000151	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.26e-05	0.00015	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ADRA2A—epilepsy syndrome	1.26e-05	0.00015	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—BCHE—epilepsy syndrome	1.26e-05	0.000149	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.25e-05	0.000149	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	1.25e-05	0.000149	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TSC1—epilepsy syndrome	1.25e-05	0.000148	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PTK2B—epilepsy syndrome	1.25e-05	0.000148	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	1.24e-05	0.000148	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.23e-05	0.000147	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—AGT—epilepsy syndrome	1.23e-05	0.000146	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.22e-05	0.000146	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.22e-05	0.000145	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PTK2B—epilepsy syndrome	1.22e-05	0.000145	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TSC1—epilepsy syndrome	1.22e-05	0.000145	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NTRK2—epilepsy syndrome	1.21e-05	0.000144	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCR2—epilepsy syndrome	1.21e-05	0.000144	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SST—epilepsy syndrome	1.21e-05	0.000144	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—AQP1—epilepsy syndrome	1.2e-05	0.000143	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—DUSP6—epilepsy syndrome	1.2e-05	0.000143	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—AGT—epilepsy syndrome	1.2e-05	0.000143	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—SLC2A1—epilepsy syndrome	1.2e-05	0.000142	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.19e-05	0.000141	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCR2—epilepsy syndrome	1.19e-05	0.000141	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NTRK2—epilepsy syndrome	1.19e-05	0.000141	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SST—epilepsy syndrome	1.19e-05	0.000141	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PLCB1—epilepsy syndrome	1.18e-05	0.000141	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PLAT—epilepsy syndrome	1.18e-05	0.000141	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—TH—epilepsy syndrome	1.18e-05	0.00014	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—DUSP6—epilepsy syndrome	1.18e-05	0.00014	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	1.17e-05	0.000139	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.16e-05	0.000138	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PLAT—epilepsy syndrome	1.16e-05	0.000138	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCL12—epilepsy syndrome	1.14e-05	0.000136	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.14e-05	0.000136	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—POMC—epilepsy syndrome	1.14e-05	0.000136	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.14e-05	0.000135	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—AQP1—epilepsy syndrome	1.13e-05	0.000135	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.13e-05	0.000135	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—JUNB—epilepsy syndrome	1.12e-05	0.000133	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CNR1—epilepsy syndrome	1.12e-05	0.000133	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.12e-05	0.000133	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCL12—epilepsy syndrome	1.12e-05	0.000133	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PLCB1—epilepsy syndrome	1.12e-05	0.000133	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—POMC—epilepsy syndrome	1.12e-05	0.000133	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PRKCB—epilepsy syndrome	1.11e-05	0.000132	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL6ST—epilepsy syndrome	1.11e-05	0.000132	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.1e-05	0.000131	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CNR1—epilepsy syndrome	1.1e-05	0.00013	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—JUNB—epilepsy syndrome	1.1e-05	0.00013	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HTR7—epilepsy syndrome	1.09e-05	0.00013	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PLCB1—epilepsy syndrome	1.09e-05	0.00013	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	1.09e-05	0.00013	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CHRM3—epilepsy syndrome	1.09e-05	0.00013	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HTR7—epilepsy syndrome	1.07e-05	0.000127	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HBEGF—epilepsy syndrome	1.06e-05	0.000126	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AKT3—epilepsy syndrome	1.04e-05	0.000124	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HBEGF—epilepsy syndrome	1.04e-05	0.000123	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—POMC—epilepsy syndrome	1.04e-05	0.000123	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.03e-05	0.000122	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.03e-05	0.000122	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AKT3—epilepsy syndrome	1.02e-05	0.000121	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ADAM10—epilepsy syndrome	1.02e-05	0.000121	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	1.01e-05	0.00012	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—POMC—epilepsy syndrome	1.01e-05	0.00012	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	9.95e-06	0.000118	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	9.91e-06	0.000118	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—HMOX1—epilepsy syndrome	9.85e-06	0.000117	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CAT—epilepsy syndrome	9.72e-06	0.000116	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	9.62e-06	0.000114	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	9.53e-06	0.000113	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	9.51e-06	0.000113	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ABCB1—epilepsy syndrome	9.45e-06	0.000112	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	9.41e-06	0.000112	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	9.32e-06	0.000111	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	9.3e-06	0.000111	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	9.2e-06	0.000109	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	9e-06	0.000107	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ABCG2—epilepsy syndrome	8.88e-06	0.000106	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GPX1—epilepsy syndrome	8.79e-06	0.000105	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	8.7e-06	0.000103	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	8.65e-06	0.000103	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	8.6e-06	0.000102	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	8.51e-06	0.000101	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	8.46e-06	0.000101	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	8.43e-06	0.0001	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	8.42e-06	0.0001	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	8.37e-06	9.95e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	8.28e-06	9.84e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	8.25e-06	9.81e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	8.23e-06	9.79e-05	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	8.2e-06	9.75e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	8.15e-06	9.7e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	8.14e-06	9.67e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	8.1e-06	9.64e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	8.04e-06	9.57e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	7.96e-06	9.46e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	7.87e-06	9.36e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	7.83e-06	9.3e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	7.76e-06	9.23e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—AGT—epilepsy syndrome	7.71e-06	9.16e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	7.66e-06	9.11e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	7.65e-06	9.1e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—APOE—epilepsy syndrome	7.55e-06	8.98e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	7.49e-06	8.91e-05	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.4e-06	8.8e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	7.39e-06	8.79e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—BCHE—epilepsy syndrome	7.36e-06	8.75e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	7.27e-06	8.65e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	7.27e-06	8.64e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	7.12e-06	8.47e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	7.12e-06	8.46e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	7.11e-06	8.45e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	7.02e-06	8.35e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	6.97e-06	8.29e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	6.96e-06	8.28e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	6.96e-06	8.28e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PLCB1—epilepsy syndrome	6.94e-06	8.25e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—BCHE—epilepsy syndrome	6.93e-06	8.24e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—TH—epilepsy syndrome	6.92e-06	8.23e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	6.82e-06	8.11e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	6.71e-06	7.98e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	6.69e-06	7.95e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	6.61e-06	7.86e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	6.57e-06	7.81e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	6.54e-06	7.78e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	6.54e-06	7.78e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—TH—epilepsy syndrome	6.52e-06	7.75e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—POMC—epilepsy syndrome	6.49e-06	7.71e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	6.12e-06	7.27e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	5.98e-06	7.12e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	5.98e-06	7.11e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ALB—epilepsy syndrome	5.91e-06	7.03e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	5.85e-06	6.96e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—HMOX1—epilepsy syndrome	5.77e-06	6.86e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CAT—epilepsy syndrome	5.7e-06	6.77e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	5.44e-06	6.47e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	5.41e-06	6.43e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CAT—epilepsy syndrome	5.37e-06	6.38e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	5.29e-06	6.29e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	5.22e-06	6.21e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	5.17e-06	6.15e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GPX1—epilepsy syndrome	5.15e-06	6.13e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	5.02e-06	5.97e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	4.92e-06	5.85e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	4.91e-06	5.84e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GPX1—epilepsy syndrome	4.85e-06	5.77e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	4.82e-06	5.73e-05	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.57e-06	5.43e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	4.53e-06	5.38e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—AGT—epilepsy syndrome	4.52e-06	5.37e-05	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	4.47e-06	5.32e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	4.43e-06	5.27e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—APOE—epilepsy syndrome	4.43e-06	5.26e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	4.4e-06	5.23e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	4.3e-06	5.12e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	4.28e-06	5.09e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—AGT—epilepsy syndrome	4.26e-06	5.06e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	4.19e-06	4.98e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—APOE—epilepsy syndrome	4.17e-06	4.96e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	4.15e-06	4.93e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	4.06e-06	4.83e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	3.95e-06	4.69e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	3.86e-06	4.59e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	3.84e-06	4.57e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—POMC—epilepsy syndrome	3.8e-06	4.52e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	3.76e-06	4.47e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—POMC—epilepsy syndrome	3.58e-06	4.26e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ALB—epilepsy syndrome	3.47e-06	4.12e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ALB—epilepsy syndrome	3.27e-06	3.88e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTGS2—epilepsy syndrome	3.03e-06	3.61e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	2.86e-06	3.4e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—AKT1—epilepsy syndrome	2.6e-06	3.09e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	2.45e-06	2.92e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	2.4e-06	2.85e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.52e-06	1.81e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.44e-06	1.71e-05	CbGpPWpGaD
